Literature DB >> 2998757

Cell-type preference of immunoglobulin kappa and lambda gene promoters.

D Picard, W Schaffner.   

Abstract

Immunoglobulin gene constant regions are known to be associated with strictly tissue-specific enhancer elements. Until recently the promoter of the variable region, which becomes linked to the constant region by somatic rearrangement, could have been viewed as a passive recipient of the enhancer stimulus. Here we show that the promoters of the immunoglobulin kappa and lambda light chain genes are approximately 20-30 times more active in lymphoid cells than in non-lymphoid cells. To avoid the problem of differential mRNA stability upon transfection of immunoglobulin genes into non-lymphoid cells we have constructed chimeric genes. All kappa mRNA sequences were progressively deleted to fuse the kappa gene promoter to a globin gene coding body. A similar chimeric gene was constructed with the promoter of the lambda gene. The cell-type preference of the promoter may be exploited during B-lymphocyte differentiation to regulate the immunoglobulin gene promoter independently from the enhancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998757      PMCID: PMC554586          DOI: 10.1002/j.1460-2075.1985.tb04011.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  A kappa-immunoglobulin gene is formed by site-specific recombination without further somatic mutation.

Authors:  J G Seidman; E E Max; P Leder
Journal:  Nature       Date:  1979-08-02       Impact factor: 49.962

2.  Sequences of mouse immunoglobulin light chain genes before and after somatic changes.

Authors:  O Bernard; N Hozumi; S Tonegawa
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

3.  The arrangement and rearrangement of antibody genes.

Authors:  J G Seidman; P Leder
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

4.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

5.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

6.  Variable and constant parts of the immunoglobulin light chain gene of a mouse myeloma cell are 1250 nontranslated bases apart.

Authors:  C Brack; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  The isolation of structural genes from libraries of eucaryotic DNA.

Authors:  T Maniatis; R C Hardison; E Lacy; J Lauer; C O'Connell; D Quon; G K Sim; A Efstratiadis
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

9.  Relationship between an enhancer element in the human antithrombin III gene and an immunoglobulin light-chain gene enhancer.

Authors:  E V Prochownik
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

10.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

Authors:  M S Neuberger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  54 in total

1.  Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.

Authors:  I Kemler; E Bucher; K Seipel; M M Müller-Immerglück; W Schaffner
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

2.  Identification of a novel factor that interacts with an immunoglobulin heavy-chain promoter and stimulates transcription in conjunction with the lymphoid cell-specific factor OTF2.

Authors:  B K Yoza; R G Roeder
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

3.  Structure and expression of the human immunoglobulin lambda genes.

Authors:  T J Vasicek; P Leder
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

4.  Interaction of a nuclear protein with a palindromic sequence of the mouse immunoglobulin lambda 2-chain gene promoter is important for its transcription.

Authors:  L A Chang; H Murialdo
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

5.  The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.

Authors:  K B Meyer; M J Sharpe; M A Surani; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

6.  Every enhancer works with every promoter for all the combinations tested: could new regulatory pathways evolve by enhancer shuffling?

Authors:  M Kermekchiev; M Pettersson; P Matthias; W Schaffner
Journal:  Gene Expr       Date:  1991-04

7.  Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.

Authors:  J M Pongubala; M L Atchison
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

8.  Positive and negative regulation of immunoglobulin gene expression by a novel B-cell-specific enhancer element.

Authors:  J Wang; M Oketani; T Watanabe
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

9.  Protein-nucleotide contacts in the immunoglobulin heavy-chain promoter region.

Authors:  N F Landolfi; J D Capra; P W Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Two different IFN-gamma nonresponsive variants derived from the B-cell lymphoma 70Z/3.

Authors:  L D Rhodes; A T Paull; C H Sibley
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.